Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:
- National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
- Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
- Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
- Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.
Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:
- Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
- MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
- Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.
Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.
Leidos (NYSE:LDOS) secured a prime contract worth up to $545 million from the National Institute of Allergy and Infectious Diseases (NIAID) on March 9, 2022. This seven-year contract will enhance biomedical preclinical and development capabilities. Services include chemistry manufacturing, bioinformatics, and analytics. Leidos has supported U.S. biomedical research for over two decades, managing large contracts related to various diseases. The company reported $13.7 billion in revenue for fiscal 2021, underscoring its strong market presence.
Clearsense has announced a strategic partnership with Leidos (NYSE: LDOS) to enhance healthcare data management. The collaboration aims to provide a comprehensive managed services suite that delivers measurable ROI for healthcare organizations. This partnership builds on a previous successful project that saved a healthcare system around $20 million. Clearsense's innovative technology will streamline data processes, significantly reducing costs while improving patient care. This collaboration was highlighted at the ViVE 2022 event in Miami from March 6-9, 2022.
Leidos (NYSE: LDOS) has appointed retired Major General John George as its Army Strategic Account Executive. This role aims to enhance relationships with the United States Army and foster organic growth within the company. General George, with 33 years of experience in the Army, previously led the Combat Capabilities Development Command, overseeing a $13 billion modernization budget. His extensive background in military operations and technology development is expected to strengthen Leidos' market position and support its mission-critical initiatives.
Leidos (NYSE:LDOS) has appointed Maureen Waterston as the new Chief Human Resources Officer (CHRO), effective March 1, 2022. Waterston will enhance the human capital strategy for Leidos' 43,000-employee workforce. She previously served as CHRO at Pratt & Whitney and has extensive HR experience in global roles at United Technologies Corporation and Otis Elevator. Leidos reported approximately $13.7 billion in annual revenues for the fiscal year ending December 31, 2021, and operates in defense, intelligence, civil, and health markets.
Leidos has secured an $11.5 billion contract from the Defense Information Systems Agency for the Defense Enclave Services (DES) initiative. The contract spans four years, with options for three additional two-year periods. Leidos aims to enhance mission capabilities and user experience through a unified network architecture. CEO Roger Krone praised the award, emphasizing the company’s commitment to delivering critical support to military efforts. The firm reported revenues of approximately $13.7 billion for the fiscal year ending December 31, 2021.
Leidos (NYSE: LDOS) has appointed Patrick Shanahan, former Deputy Secretary of Defense, to its Board of Directors effective February 16, 2022. Shanahan brings extensive experience in defense policies, having contributed to major strategies like the 2018 National Defense Strategy and the establishment of the Joint Artificial Intelligence Center. Leidos Chairman Roger Krone highlighted Shanahan's expertise as an asset for advancing technology and cybersecurity initiatives. Leidos reported $13.7 billion in revenues for FY 2021, emphasizing its role in defense and technology sectors.
Leidos Holdings reported a strong performance for FY 2021, with revenues of $13.74 billion, up 12% year-over-year. The fourth quarter revenues reached $3.49 billion, a 7% increase. Net income was $759 million for the year, translating to $5.27 EPS, a 21% rise compared to 2020. The company achieved a 10% adjusted EBITDA margin and a significant cash flow conversion of 98%. Leidos announced FY 2022 guidance projecting revenues between $13.9 - $14.3 billion, despite potential impacts from tax legislation on R&D costs.
Leidos Holdings, Inc. (NYSE: LDOS) has announced a quarterly cash dividend of $0.36 per share, payable on March 31, 2022, to stockholders of record by March 15, 2022. This dividend reflects the company’s commitment to returning value to its shareholders. Leidos, a Fortune 500 company, reported revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021. With a workforce of about 43,000 employees, Leidos continues to address significant challenges across various sectors including defense and health.
Leidos (NYSE: LDOS) has secured a prime contract worth $104 million from the U.S. Army to modernize its gunnery training simulation systems. This indefinite delivery, indefinite quantity contract spans five years and will be executed in Orlando, Florida. The project aims to enhance the training capabilities for warfighters through technology updates to existing simulators, which connect weaponry to virtual systems. The news underscores Leidos' ongoing commitment to support the Army's training missions.
Leidos (NYSE: LDOS) will join the Cowen 43rd Annual Aerospace/Defense & Industrials Conference on February 8, 2022, at 1:30 PM ET. The CEO, Roger Krone, will engage in a fireside chat during the event. A live audio webcast will be available on Leidos' Investor Relations website, with a replay accessible for 90 days afterward. Leidos, a FORTUNE 500® company, reported approximately $12.30 billion in revenues for FY ending January 1, 2021, and is headquartered in Reston, VA.
FAQ
What is the current stock price of Leidos Holdings (LDOS)?
What is the market cap of Leidos Holdings (LDOS)?
What does Leidos Holdings, Inc. do?
Where is Leidos Holdings, Inc. headquartered?
How many employees does Leidos have?
What are the main business segments of Leidos?
What were Leidos' revenues for the fiscal year 2023?
What is C2IMERA?
What is MHS GENESIS?
What recent project has Leidos completed for the Air Force Research Lab?
What are the recent financial highlights for Leidos?
How does Leidos contribute to national security?
